ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $272 | +68.9% | 6,845 | +70.9% | 0.00% | +50.0% |
| Q4 2022 | $161 | -99.9% | 4,005 | -29.5% | 0.00% | 0.0% |
| Q2 2022 | $168,000 | -26.0% | 5,677 | -29.6% | 0.00% | 0.0% |
| Q1 2022 | $227,000 | -58.5% | 8,061 | -32.1% | 0.00% | -33.3% |
| Q4 2021 | $547,000 | +32.1% | 11,875 | -5.9% | 0.00% | +50.0% |
| Q3 2021 | $414,000 | +162.0% | 12,624 | +132.0% | 0.00% | +100.0% |
| Q4 2020 | $158,000 | -10.7% | 5,442 | -13.2% | 0.00% | 0.0% |
| Q3 2020 | $177,000 | -79.6% | 6,266 | -70.6% | 0.00% | -87.5% |
| Q1 2020 | $869,000 | +727.6% | 21,338 | +1149.3% | 0.01% | +700.0% |
| Q4 2019 | $105,000 | -95.3% | 1,708 | -94.4% | 0.00% | -94.4% |
| Q3 2019 | $2,226,000 | +208.7% | 30,544 | +248.2% | 0.02% | +260.0% |
| Q2 2019 | $721,000 | -84.9% | 8,771 | -87.1% | 0.01% | -88.6% |
| Q1 2019 | $4,790,000 | +3114.8% | 67,904 | +1954.0% | 0.04% | +4300.0% |
| Q4 2018 | $149,000 | -68.3% | 3,306 | -60.3% | 0.00% | -66.7% |
| Q3 2018 | $470,000 | -36.7% | 8,321 | -25.1% | 0.00% | -57.1% |
| Q2 2018 | $743,000 | +115.4% | 11,116 | +87.8% | 0.01% | +133.3% |
| Q1 2018 | $345,000 | +11.3% | 5,918 | +22.9% | 0.00% | 0.0% |
| Q4 2017 | $310,000 | +57.4% | 4,815 | +28.2% | 0.00% | +50.0% |
| Q3 2017 | $197,000 | -93.7% | 3,755 | -95.9% | 0.00% | -90.9% |
| Q1 2016 | $3,114,000 | +65.2% | 92,513 | +121.4% | 0.02% | +69.2% |
| Q4 2015 | $1,885,000 | +20.6% | 41,782 | +5.6% | 0.01% | +44.4% |
| Q3 2015 | $1,563,000 | -32.3% | 39,566 | +6.3% | 0.01% | -40.0% |
| Q2 2015 | $2,309,000 | +3.2% | 37,210 | +4.0% | 0.02% | +15.4% |
| Q1 2015 | $2,238,000 | +235.5% | 35,775 | +202.5% | 0.01% | +333.3% |
| Q4 2014 | $667,000 | +77.9% | 11,826 | +8.7% | 0.00% | +50.0% |
| Q2 2014 | $375,000 | +89.4% | 10,883 | +72.3% | 0.00% | +100.0% |
| Q1 2014 | $198,000 | – | 6,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |